Indivior (INDV) earnings

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $4.1B

In the quarter ended June 2026, Indivior had revenue of $343M, up 13.6% on a year earlier, and diluted EPS of 0.98.

On August 3, 2026 it reported EPS of 1.15 against an estimate of 0.97 (beat).

The next report is expected on Thursday, October 29, 2026, with EPS expected around 0.93.

Report dates

ReportDateTimeEPS estimateEPS reported
NextThu Oct 29, 2026 — 0.93 —
LastMon Aug 3, 2026 — 0.97 1.15

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Quarterly results

The last 10 quarters from Indivior's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Jun 30, 2026$343M +13.6% 0.98 +600.0% 46.6% 2026-08-03
Mar 31, 2026$317M +19.2% 0.69 +81.6% 43.2% 2026-04-30
Dec 31, 2025$358M +19.7% — — 22.6% 2026-02-26
Sep 30, 2025$314M +2.3% 0.33 +106.2% 13.7% 2025-10-30
Jun 30, 2025$302M +1.0% 0.14 — 23.8% 2025-07-31
Mar 31, 2025$266M -6.3% 0.38 -15.6% 24.8% 2025-05-01
Dec 31, 2024$299M — — — 15.4% 2025-03-03
Sep 30, 2024$307M — 0.16 — 11.4% 2025-05-01
Jun 30, 2024$299M — -0.72 — -39.5% 2025-05-01
Mar 31, 2024$284M — 0.45 — 26.4% 2025-05-01
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INDV.
Open INDV in Investingly

Questions

When does Indivior report earnings?

Indivior's next earnings report is expected on October 29, 2026.

How did Indivior do last quarter?

In the quarter ended June 2026, Indivior had revenue of $343M, up 13.6% on a year earlier, and diluted EPS of 0.98.

From Indivior's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.